Nordic Life Science 1
weden has also been very accomplished in the fiel
d of small molecular drug development, according to Mangsbo, who hopes Sweden can now be as strong in competence in the field of biologics. “I hope that we will see transformations around innovation and that we can overcome some of the challenges [of working with other entities] so that researchers can join forces, not only with universities and companies, but also with hospitals and make use of the knowledge there.” Mangsbo enjoys contributing to the future knowledge base through her teaching. “I also think that it is important, being a part of another person’s future and helping them understand immunology and biology and drugs,” she says. “We need to build a strong life science sector, or we won’t be competitive. I know I can generate that interest by communicating those things in a better way. I have a deep interest in my subject, and I can communicate that to my students and hopefully that leads to their interest as well.” With all Mangsbo has to do, she does enjoy her downtime, much of which is spent hanging around with her two daughters, ages 5 and 7, riding bicycles and exploring the nature near their home in Uppsala. She also enjoys the nature in Bergslagen, and spends time in a house near Ludvika, exploring the nature around there. CONTINUING TO EDUCATE future generations and bring promising drugs to market are among Mangbo’s long-term career goals. “I hope that I still can use my energy to teach others, that I can be a pillar in bringing strategies to treatment. I hope my work will eventually result in a drug being approved. I hope I can see that my work brings something to patients. I want to maintain that energy to bring innovation to people,” she concludes. NLS 78 NORDICLIFESCIENCE.ORG